Principal Financial Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-16,402
| Closed | -$2.48M | – | 2612 |
|
|
2022
Q3 | $2.48M | Sell |
16,402
-4,408
| -21% | -$666K | ﹤0.01% | 1683 |
|
|
2022
Q2 | $3.03M | Sell |
20,810
-4,762
| -19% | -$694K | ﹤0.01% | 1714 |
|
|
2022
Q1 | $3.03M | Sell |
25,572
-5,622
| -18% | -$667K | ﹤0.01% | 1800 |
|
|
2021
Q4 | $4.3M | Sell |
31,194
-3,576
| -10% | -$493K | ﹤0.01% | 1720 |
|
|
2021
Q3 | $4.83M | Buy |
34,770
+12,628
| +57% | +$1.75M | ﹤0.01% | 1700 |
|
|
2021
Q2 | $2.15M | Sell |
22,142
-165,728
| -88% | -$16.1M | ﹤0.01% | 1887 |
|
|
2021
Q1 | $12.8M | Buy |
187,870
+158,523
| +540% | +$10.8M | 0.01% | 1249 |
|
|
2020
Q4 | $2.52M | Buy |
29,347
+4,339
| +17% | +$372K | ﹤0.01% | 1753 |
|
|
2020
Q3 | $1.63M | Sell |
25,008
-87
| -0.3% | -$5.65K | ﹤0.01% | 1776 |
|
|
2020
Q2 | $1.84M | Buy |
25,095
+17,036
| +211% | +$1.25M | ﹤0.01% | 1714 |
|
|
2020
Q1 | $274K | Sell |
8,059
-4,630
| -36% | -$157K | ﹤0.01% | 1984 |
|
|
2019
Q4 | $691K | Buy |
12,689
+1,541
| +14% | +$83.9K | ﹤0.01% | 1885 |
|
|
2019
Q3 | $465K | Buy |
11,148
+5,216
| +88% | +$218K | ﹤0.01% | 1959 |
|
|
2019
Q2 | $260K | Buy |
5,932
+21
| +0.4% | +$920 | ﹤0.01% | 2093 |
|
|
2019
Q1 | $304K | Buy |
5,911
+371
| +7% | +$19.1K | ﹤0.01% | 2034 |
|
|
2018
Q4 | $205K | Sell |
5,540
-99
| -2% | -$3.66K | ﹤0.01% | 2127 |
|
|
2018
Q3 | $212K | Buy |
5,639
+276
| +5% | +$10.4K | ﹤0.01% | 2156 |
|
|
2018
Q2 | $212K | Buy |
+5,363
| New | +$212K | ﹤0.01% | 2153 |
|